These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25104458)

  • 1. Metabolic memory: mechanisms and implications for diabetic vasculopathies.
    Zhang E; Wu Y
    Sci China Life Sci; 2014 Aug; 57(8):845-51. PubMed ID: 25104458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications.
    Rodriguez H; El-Osta A
    Antioxid Redox Signal; 2018 Oct; 29(11):1074-1091. PubMed ID: 29304555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging challenge in diabetes: the "metabolic memory".
    Ceriello A
    Vascul Pharmacol; 2012; 57(5-6):133-8. PubMed ID: 22609133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epigenetic mechanisms in the vascular complications of diabetes.
    Reddy MA; Natarajan R
    Subcell Biochem; 2013; 61():435-54. PubMed ID: 23150262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms of endothelial dysfunction in diabetes.
    Roberts AC; Porter KE
    Diab Vasc Dis Res; 2013 Nov; 10(6):472-82. PubMed ID: 24002671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of diabetic microangiopathy.
    Mokini Z; Chiarelli F
    Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):138-52. PubMed ID: 17342030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture.
    Natarajan R
    Diabetes; 2021 Feb; 70(2):328-337. PubMed ID: 33472942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic microvascular complications and growth factors.
    Pfeiffer A; Schatz H
    Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes.
    Lyons TJ
    Semin Vasc Med; 2002 May; 2(2):175-89. PubMed ID: 16222609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications.
    Rajasekar P; O'Neill CL; Eeles L; Stitt AW; Medina RJ
    J Diabetes Res; 2015; 2015():436879. PubMed ID: 26106624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis: the "metabolic memory", the new challenge of diabetes.
    Ceriello A
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S2-6. PubMed ID: 20115927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms in diabetic vascular complications.
    Reddy MA; Natarajan R
    Cardiovasc Res; 2011 Jun; 90(3):421-9. PubMed ID: 21266525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemic memory in metabolism and cancer.
    Lee C; An D; Park J
    Horm Mol Biol Clin Investig; 2016 May; 26(2):77-85. PubMed ID: 27227713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.